BIOQUAL, Inc.
BIOQ
$72.50
-$2.50-3.33%
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 61.62M | 62.43M | 62.66M | 64.94M | 67.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.62M | 62.43M | 62.66M | 64.94M | 67.96M |
| Cost of Revenue | 50.80M | 50.51M | 50.06M | 49.86M | 50.40M |
| Gross Profit | 10.82M | 11.92M | 12.60M | 15.08M | 17.56M |
| SG&A Expenses | 11.77M | 11.61M | 11.50M | 11.15M | 10.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.57M | 62.12M | 61.56M | 61.01M | 61.21M |
| Operating Income | -947.60K | 315.90K | 1.10M | 3.93M | 6.76M |
| Income Before Tax | -741.50K | 418.70K | 1.13M | 3.98M | 6.80M |
| Income Tax Expenses | -283.80K | 67.30K | 297.70K | 558.20K | 1.38M |
| Earnings from Continuing Operations | -0.46 | 0.35 | 0.84 | 3.43 | 5.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -457.60K | 351.50K | 835.60K | 3.43M | 5.42M |
| EBIT | -947.60K | 315.90K | 1.10M | 3.93M | 6.76M |
| EBITDA | 1.58M | 2.77M | 3.38M | 6.03M | 8.68M |
| EPS Basic | -0.51 | 0.39 | 0.93 | 3.83 | 6.06 |
| Normalized Basic EPS | -0.52 | 0.29 | 0.79 | 2.78 | 4.75 |
| EPS Diluted | -0.52 | 0.39 | 0.93 | 3.83 | 6.06 |
| Normalized Diluted EPS | -0.52 | 0.29 | 0.79 | 2.78 | 4.75 |
| Average Basic Shares Outstanding | 3.58M | 3.58M | 3.58M | 3.58M | 3.58M |
| Average Diluted Shares Outstanding | 3.58M | 3.58M | 3.58M | 3.58M | 3.58M |
| Dividend Per Share | 0.50 | 0.50 | 0.50 | 1.00 | 1.00 |
| Payout Ratio | -97.73% | 254.45% | 107.04% | 26.11% | 16.50% |
